Clinical trials
Patient clinical trials
Below are recruiting patient clinical trials, each written for real people, not researchers. We’re tracking 14,824 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06515587Recruiting
Lewis antigen test for pancreatic cancer prognosis
This study looks at how a special blood test (Lewis antigen) combined with a standard CA19-9 test might help predict the outlook for people with pancreatic cancer. You will give a small extra blood sample and have routine follow-up tests.
Shanghai, Shanghai MunicipalityAges 18–75 - NCT06572319RecruitingPhase 1/Phase 2
Combination drug trial for HER2-positive stomach cancer
This trial tests two drugs, disitamab vedotin and trastuzumab, for people with HER2-positive stomach or gastroesophageal junction cancer that has spread or come back after at least one prior treatment. The goal is to see if this combination can help shrink tumors.
Hangzhou, ZhejiangAges 18–75 - NCT06511739RecruitingPhase 2
SYHX1901 tablet for non-segmental vitiligo
This study tests an oral tablet called SYHX1901 for people with non-segmental vitiligo. It aims to see if the pill is safe and effective at bringing back skin color.
ShijiazhuangAges 18–65 - NCT06583616Recruiting
Can blood gas levels predict survival after a pulmonary embolism?
This study looks at whether a simple blood test (the anion gap) can help predict survival in patients with acute pulmonary embolism. It aims to find out if this measurement can guide treatment decisions.
Semarang, Central of JavaAges 18–70 - NCT06569771Recruiting
How patients feel about using their arm after stroke rehab
This study looks at how people feel about using their arm after a stroke during intensive rehab. It helps understand if therapy makes a difference in how you use your arm in daily life.
Charleroi, HainautAges 18 years+ - NCT06581874Recruiting
Mental health care follow-up after emergency visit
This study is testing a new way of coordinating mental health care between the hospital and community providers. It aims to see if this collaborative approach helps people who need follow-up after an emergency visit or a referral through the Med@psy program.
Toulon, VarAges 18 years+ - NCT06517355Recruiting
Onco-sexology program for laryngectomy patients and partners
This study tests an onco-sexology program designed to help patients who have had their voice box removed (laryngectomy) and their partners improve their intimate life and well-being after cancer treatment.
ToulouseAges 18 years+ - NCT06514820Recruiting
Exercise MRI study for obesity-related heart failure
This study uses an exercise test with MRI to understand how obesity affects the heart in people with heart failure. It aims to find better ways to diagnose and help patients.
GroningenAges 18 years+ - NCT06548529Recruiting
HER2 PET/CT scan to predict treatment response in bladder cancer
This trial uses a special PET/CT scan to see if your bladder cancer has HER2 proteins, which can help predict how well you will respond to a targeted antibody-drug conjugate treatment. It is for people with advanced bladder cancer who have already tried certain standard therapies.
BeijingAges 18–80 - NCT06554509RecruitingPhase 2/Phase 3
Study of SHR-1819 for prurigo nodularis
This trial tests an injection called SHR-1819 for adults with prurigo nodularis, a skin condition with itchy bumps. The goal is to see if it helps reduce itching and bumps.
Beijing, Beijing MunicipalityAges 18 years+ - NCT06525532Recruiting
Tracking reabsorbable implant for flatfoot in kids
This study tracks how well a special reabsorbable implant works over time in children and teens who had subtalar surgery for flatfoot. You'll have an MRI to see how the implant has changed and if it helped your foot.
BolognaAges 8–15 - NCT06534840Recruiting
Predicting lung problems after liver transplant
This study uses a computer program to predict lung problems after a liver transplant. It may help doctors better care for people like you.
Chengdu, SichuanAges 18–80 - NCT06541158Recruiting
Help with transportation for cancer treatment
This study tests a tool to help patients with solid tumors who are getting radiation therapy overcome transportation problems. If you have trouble getting to appointments, this could help you find ways to get there more easily.
Atlanta, GeorgiaAges 18 years+ - NCT06581900Recruiting
Vitamin B12 in kids with sickle cell disease
This study looks at how children with sickle cell disease process vitamin B12 when exposed to a gas painkiller called MEOPA. It may help doctors understand how to manage treatment better.
ReimsAges 2–18 - NCT06568913Recruiting
TPO-RA medicines for children with long-term ITP
This study looks at how well certain medicines (called thrombopoietin receptor agonists, or TPO-RAs) work for children with long-term ITP that did not improve with steroids. The goal is to see if these medicines can help raise platelet counts and reduce bleeding.
SohagAges 1–18 - NCT06524583RecruitingPhase 2
Chemotherapy after surgery for high-risk uterine leiomyosarcoma
This trial tests whether chemotherapy after surgery can help prevent uterine leiomyosarcoma from coming back in patients who are at high risk based on a genetic test of their tumor. It is for women with early-stage cancer (stage I) who have had complete surgery.
AngersAges 18–75 - NCT06577675Recruiting
DBT group therapy for emotional dysregulation
This study tests a group therapy program (DBT) for people who have trouble managing their emotions. It includes those with different diagnoses (like borderline disorder, bipolar disorder, or PTSD) and aims to see how they improve over time.
Saint-Etienne, Saint Priest En JarezAges 18–65 - NCT06584097Recruiting
Comparing general purpose models during recovery after brain surgery
This trial compares how well general purpose models work during sedation after planned brain surgery. It is for adults who will be sedated for more than 12 hours after surgery and need an arterial line for blood pressure monitoring.
Milan, ItalyAges Any age - NCT06584773RecruitingPhase 4
Stronger immune therapy for high-antibody kidney transplant patients
This trial is testing a stronger combination of four immune-suppressing medicines (including mTOR inhibitors) to help prevent rejection in kidney transplant patients who have a high level of antibodies. It aims to see if this approach works better than standard care for these 'sensitized' patients.
São PauloAges 18–60 - NCT06518135Recruiting
Sentinel node biopsy after chemo for initial node-positive breast cancer
This trial checks whether a less invasive sentinel lymph node biopsy (removing just a few nodes) can safely replace full lymph node removal for people whose breast cancer and underarm lymph nodes responded well to chemotherapy. It is for patients who initially had 1 to 3 involved nodes and now appear cancer-free in the armpit.
Henan, HenanAges 18–70 - NCT06493799RecruitingPhase 3
Injectable placenta extract for fatty liver disease
This trial tests an injectable medication made from human placenta to see if it can improve liver health in people with fatty liver disease (from alcohol or other causes). It may help lower liver enzyme levels and reduce liver damage.
Yongin-siAges 19–70 - NCT06549231RecruitingPhase 3
Rituximab and mycophenolate for scleroderma lung disease
This trial tests whether combining two drugs, rituximab and mycophenolate mofetil, is safe and works better than standard care for lung scarring caused by scleroderma. It may be an option if your lung disease is severe or getting worse.
ToursAges 18–100 - NCT06568679Recruiting
Improving detection and treatment of early-onset colorectal cancer
This study aims to find better ways to detect and treat colorectal cancer in younger adults (ages 18–49). It includes people with both early-stage and advanced cancer.
Amsterdam, North HollandAges 18–49 - NCT06583811Recruiting
Sedatives for staying still during long eye surgery
This trial tests two sedative medications, remifentanil and remimazolam, to see which one better keeps patients still during long eye surgeries. It aims to make surgery safer and more comfortable for you.
CairoAges 40–50
Hear when a new Patient trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for patient?
- Yes. Clin2 currently lists 14,824 recruiting patient studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a patient trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a patient trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.